Zum Inhalt springen
Psoriasis-News
  • Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trial - PubMed

     Teilen


    Background: The role of methotrexate in combination with biological agents in patients with psoriatic arthritis remains unclear. The MUST phase 3b …

    Den ganzen Artikel lesen


    Automat
     Teilen



×
×
  • Neu erstellen...